Our lab focuses on developing gene therapies for diseases with mitochondrial dysfunctions. Currently, we are focusing on diseases including Leigh syndrome, a primary mitochondrial disease, and NF2-related schwannomatosis. We combine state-of-the-art gene delivery platforms with advanced computational approaches to develop precise, efficient, and safe therapeutic strategies to accelerate discovery and translation. By integrating experimental biology with data-driven analysis, our team aims to overcome the current limitations of gene therapy and open new frontiers in personalized medicine.

Interested in our research? Please contact us